Grants and Contributions:
Title:
Eyam Vaccines and Immunotherapeutics Ltd.-2024-2025-1021687
Agreement Number:
1021687
Agreement Value:
$25,399.50
Agreement Date:
Apr 17, 2024 - Mar 31, 2025
Description:
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
Organization:
National Research Council Canada
Expected Results:
Increase Canadian science and technological innovation and commercialization opportunities as measured by analysis of recipient performance reports and surveys.
Location:
New Westminster, British Columbia, CA V3M6B9
Reference Number:
172-2024-2025-Q2-1021687
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
732113931
Recipient Type:
For-profit organization
Recipient's Operating Name:
Eyam Vaccines and Immunotherapeutics Ltd.
Recipient's Legal Name:
Eyam Vaccines and Immunotherapeutics Ltd.
Federal Riding Name:
New Westminster--Burnaby
Federal Riding Number:
59019
Program:
CanExport Innovation
Program Purpose:
The Program is designed to promote and enhance Canada’s international innovation efforts by providing direct financial assistance to the Recipient (Canadian small and medium-size enterprises, academic institutions and non-government research centres) to pursue international opportunities that could lead to the establishment of new collaborative Research and Development (R&D) partnerships with key players in foreign markets.
NAICS Code:
541710